These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 14302880)

  • 21. VIRAL INHIBITION IN THE METAPHASE-ARREST CELL.
    MARCUS PI; ROBBINS E
    Proc Natl Acad Sci U S A; 1963 Dec; 50(6):1156-64. PubMed ID: 14096191
    [No Abstract]   [Full Text] [Related]  

  • 22. INHIBITING ACTIVITY OF SULPHONIAZIDE AGAINST POLIOVIRUS AND VACCINIA VIRUS.
    LODDO B; GESSA GL; FERRARI W
    Lancet; 1964 Apr; 1(7337):796-7. PubMed ID: 14108008
    [No Abstract]   [Full Text] [Related]  

  • 23. ANTIVIRAL ACTIVITY OF TENUAZONIC ACID.
    MILLER FA; RIGHTSEL WA; SLOAN BJ; EHRLICH J; FRENCH JC; BARTZ QR; DIXON GJ
    Nature; 1963 Dec; 200():1338-9. PubMed ID: 14098497
    [No Abstract]   [Full Text] [Related]  

  • 24. INHIBITORY EFFECT OF MONONUCLEOTIDES ON VIRUS PLAQUE FORMATION.
    GIFFORD GE
    Proc Soc Exp Biol Med; 1965 May; 119():9-12. PubMed ID: 14297891
    [No Abstract]   [Full Text] [Related]  

  • 25. VACCINIA VIRUS-HELA CELL INTERACTION. II. THE EFFECT OF MITOMYCIN C ON THE PRODUCTION OF INFECTIVE VIRUS, COMPLEMENT-FIXING ANTIGEN, AND HEMAGGLUTININ.
    ODA M
    Virology; 1963 Dec; 21():533-9. PubMed ID: 14100602
    [No Abstract]   [Full Text] [Related]  

  • 26. ANTI-VIRAL ACTIVITY OF TWO GUANIDINE DERIVATIVES IN VITRO.
    LODDO B; GESSA GL
    Nature; 1965 Jan; 205():401-2. PubMed ID: 14243432
    [No Abstract]   [Full Text] [Related]  

  • 27. INHIBITORY EFFECT OF ANTIVIRAL COMPOUNDS ON COLUMBIA SK, LCM, VACCINIA AND ADENO TYPE 12 VIRUSES IN VITRO.
    FURUSAWA E; CUTTING W; FURST A
    Chemotherapia (Basel); 1964; 20():95-105. PubMed ID: 14164297
    [No Abstract]   [Full Text] [Related]  

  • 28. CYTOCHEMICAL STUDIES OF VACCINIA-VIRUS-INFECTED CELLS. II. ACTIVITY OF SOME ENZYMES IN VACCINIA-VIRUS-INFECTED CULTURES OF MOUSE L FIBROBLASTS, CLONE 929.
    BLAWAT F; ZAWISTOWSKI S; KOWALSKA Z
    Biul Inst Med Morsk Gdansk; 1964; 15():123-9. PubMed ID: 14247481
    [No Abstract]   [Full Text] [Related]  

  • 29. CONTRIBUTION TO THE CULTIVATION IN VITRO OF VACCINIA-VIRUS FOR THE PREVENTION OF VARIOLA.
    FRENKEL HS
    Isr Med J; 1963; 22():433-41. PubMed ID: 14153477
    [No Abstract]   [Full Text] [Related]  

  • 30. LEUKOCYTES AND INTERFERON IN THE HOST RESPONSE TO VIRAL INFECTIONS. I. MOUSE LEUKOCYTES AND LEUKOCYTE-PRODUCED INTERFERON IN VACCINIA VIRUS INFECTION IN VITRO.
    GLASGOW LA
    J Exp Med; 1965 Jun; 121(6):1001-18. PubMed ID: 14319399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PREPARATION OF INTERFERON FROM CULTURES OF CHICK FIBROBLASTS TREATED WITH INACTIVATED VACCINIA VIRUS.
    PETERSON OP; YUI L
    Fed Proc Transl Suppl; 1964; 23():545-6. PubMed ID: 14185904
    [No Abstract]   [Full Text] [Related]  

  • 32. [THE EFFECT OF P-FLUOROPHENYLALANINE ON THE MULTIPLICATION OF VACCINIA VIRUS IN HELA CELLS].
    NIELSEN G
    Zentralbl Bakteriol Orig; 1963 Dec; 191():256-60. PubMed ID: 14119914
    [No Abstract]   [Full Text] [Related]  

  • 33. ANTIVIRAL ACTIVITY OF N-ETHYLISATIN BETA-THIOSEMICARBAZONE IN VACCINIA-INFECTED MICE.
    POLLIKOFF R; LIEBERMAN M; LEM NE; FOLEY EJ
    J Immunol; 1965 May; 94():794-804. PubMed ID: 14296301
    [No Abstract]   [Full Text] [Related]  

  • 34. ANTIVIRAL ACTIVITY OF 2,2-DICHLORO-4'-FORMYLACETANILIDE THIOSEMICARBAZONE.
    TIPSON RS
    J Med Chem; 1963 Mar; 6():216-7. PubMed ID: 14188804
    [No Abstract]   [Full Text] [Related]  

  • 35. EFFECTS OF ACTINOMYCIN ON GROWTH AND HEMAGGLUTININ PRODUCTION OF VACCINIA VIRUS.
    FUJIO Y
    Biken J; 1963 Oct; 6():197-203. PubMed ID: 14147711
    [No Abstract]   [Full Text] [Related]  

  • 36. A NEW ANTIVIRAL AGENT: 4-BROMO-3-METHYLISOTHIAZOLE-5-CARBOXALDEHYDE THIOSEMICARBAZONE, M AND B 7714.
    SLACK R; WOOLDRIDGE KR; MCFADZEAN JA; SQUIRES S
    Nature; 1964 Nov; 204():587. PubMed ID: 14238173
    [No Abstract]   [Full Text] [Related]  

  • 37. PLAQUE FORMATION BY VACCINIA VIRUS IN TISSUE CULTURES INHIBITED BY 5-FLUORODEOXYURIDINE.
    BAXBY D; RONDLE CJ
    J Gen Microbiol; 1965 Mar; 38():423-7. PubMed ID: 14334612
    [No Abstract]   [Full Text] [Related]  

  • 38. INCORPORATION OF 5-IODO-2'-DEOXYURIDINE INTO THE DEOXYRIBONUCLEIC ACID OF VACCINIA VIRUS.
    PRUSOFF WH; BAKHLE YS; MCCREA JF
    Nature; 1963 Sep; 199():1310-1. PubMed ID: 14074618
    [No Abstract]   [Full Text] [Related]  

  • 39. [PROPERTIES OF GENETICALLY HOMOGENOUS CLONES OF VACCINIA VIRUS].
    GENDON IuZ; CHERNOS VI; GENKINA FB
    Vopr Virusol; 1964; 126():291-5. PubMed ID: 14237277
    [No Abstract]   [Full Text] [Related]  

  • 40. THERAPEUTIC ACTION OF DISTAMYCIN A ON VACCINIA VIRUS INFECTIONS IN VIVO.
    CASAZZA AM; GHIONE M
    Chemotherapia (Basel); 1964-1965; 13():80-7. PubMed ID: 14294857
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.